TI
LEGN icon

Think Investments’s Legend Biotech LEGN Stock Holding History

Think Investments’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-314,200
Closed -$13.4M – 27
2020
Q2 		$13.4M Buy
+314,200
New +$12.3M 3.29% 13

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Think Investments's LEGN Position: Q3 2020 in Review

Think Investments sold out of Legend Biotech (LEGN) in Q3 2020, closing a stake of 314,200 shares — an estimated $13.4M sold.

Think Investments first reported a position in LEGN in Q2 2020 and held it in 1 quarter. The position peaked at $13.4M in Q2 2020. 50 funds tracked by Wall St. Rank hold LEGN as of Q3 2020.

  • Think Investments reported no remaining Legend Biotech position as of Q3 2020 after selling out during the quarter.
  • Think Investments sold 314,200 Legend Biotech shares in Q3 2020, an estimated $13.4M.
  • Think Investments first reported a position in Legend Biotech in Q2 2020 and held it in 1 quarter.
  • Think Investments's Legend Biotech position peaked at $13.4M in Q2 2020.
  • 50 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2020.

Based on Think Investments's 13F filing for Q3 2020, filed 16 Nov 2020.